Welcome to episode 85 of The 5-Minute Investor Podcast, where Stockhouse columnists Jonathon Brown and me, Trevor Abes, each deliver a 2.5-minute profile on top stocks worth a spot on your radar.
This week, we’re wrestling with the fact that, for the vast majority of us, AI and the large language models we access it through are little more than a source of untrustworthy answers, imprecise but usable images and soulless rendered voices untouched by the joys and sorrows of life.
However, if we cast our gazes across the industrial spectrum, specifically towards the healthcare sector, AI’s utility becomes readily apparent.
This article is a journalistic opinion piece on AI healthcare stocks written based on independent research. It is intended to inform investors and should not be taken as a recommendation or financial advice.
Here are Jon’s show notes for episode 85:
- Jon’s promising AI healthcare stock is Diagnos (TSXV:ADK), a Canadian technology company dedicated to the early detection of critical eye-related health problems.
- Small-cap Canadian healthcare firm expands AI-screening at home and abroad.
- At the time of writing, Diagnos stock last traded at C$0.36, adding 5.88% year-over-year, while giving back 16.28% since 2021.
Here are Trevor’s show notes:
- Trevor’s healthcare stock leveraging AI for good is CeriBell (NASDAQ:CBLL), which is using AI to enhance neurological diagnoses in critical care settings.
- This healthtech company improves neurological care with AI.
- At the time of writing, CeriBell stock last traded at US$27.07, adding 139.13% year-over-year.
Here’s our most recent trio of episodes:
- Episode 82: Canadian stocks with European potential.
- Episode 83: High-quality dividend stocks.
- Episode 84: Rate-proof stocks.
Thanks for listening!
The 5-Minute Investor Podcast is on Spotify, YouTube, iHeartRadio, Stockhouse or wherever finer podcasts are found.
Join the discussion: Find out what investors are saying about these AI healthcare stocks on the Diagnos Inc. and CeriBell Inc. Bullboards and explore the rest of Stockhouse’s stock forums and message boards.